Bioavailability of lemon verbena (Aloysia triphylla) polyphenols in rats: Impact of colonic inflammation

British Journal of Nutrition

Volumn 111, Issue 10, 2014, Pages 1773-1781

  Felgines, Catherine ^a   Fraisse, Didier ^a   Besson, Catherine ^b   Vasson, Marie Paule ^a   Texier, Odile ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CRNH AUVERGNE   (France)

Author keywords

Bioavailability; Colonic inflammation; Lemon verbena polyphenols; Rats

Indexed keywords

ACTEOSIDE; CAFFEIC ACID; COUMARIC ACID; DEXTRAN SULFATE; DIOSMETIN; FLAVONE DERIVATIVE; FLAVONE DIGLUCURONIDE; LUTEOLIN; POLYPHENOL; SUGAR ACID; UNCLASSIFIED DRUG; ANTIOXIDANT;

ALOYSIA TRIPHYLLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FECES LEVEL; DRUG MECHANISM; DRUG URINE LEVEL; INTESTINE ABSORPTION; INTESTINE PERFUSION; MALE; NONHUMAN; PLANT LEAF; RAT; TREATMENT DURATION; URINARY EXCRETION; VERBENACEAE; ANALYSIS OF VARIANCE; ANIMAL; BEVERAGE; BIOAVAILABILITY; CHEMICALLY INDUCED; CHEMISTRY; COLON; DISEASE MODEL; FECES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATORY BOWEL DISEASE; METABOLISM; PHYSIOLOGY; URINE; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BEVERAGES; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FECES; INFLAMMATORY BOWEL DISEASES; INTESTINAL ABSORPTION; MALE; POLYPHENOLS; RATS; RATS, WISTAR; VERBENA;

EID: 84898860254     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514000026     Document Type: Article

References (46)

1. Atoui AK, Mansouri A, Boskou G, et al. (2005) Tea and herbal infusions: their antioxidant activity and phenolic profile. Food Chem 89, 27-36.
2. Landete JM (2012) Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health. Crit Rev Food Sci Nutr 52, 936-948.
3. Scalbert A, Manach C, Morand C, et al. (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45, 287-306.
4. Carnat A, Carnat AP, Fraisse D, et al. (1999) The aromatic and polyphenolic composition of lemon verbena tea. Fitoterapia 70, 44-49.
5. Pascual ME, Slowing K, Carretero E, et al. (2001) Lippia: traditional uses, chemistry and pharmacology: a review. J Ethnopharmacol 76, 201-214.
6. Bilia AR, Giomi M, Innocenti M, et al. (2008) HPLC-DAD-ESI-MS analysis of the constituents of aqueous preparations of verbena and lemon verbena and evaluation of the antioxidant activity. J Pharm Biomed Anal 46, 463-470.
7. Valentao P, Fernandes E, Carvalho F, et al. (2002) Studies on the antioxidant activity of Lippia citriodora infusion: scavenging effect on superoxide radical, hydroxyl radical and hypochlorous acid. Biol Pharm Bull 25, 1324-1327.
8. Romier B, Schneider YJ, Larondelle Y, et al. (2009) Dietary polyphenols can modulate the intestinal inflammatory response. Nutr Rev 67, 363-378.
9. Biasi F, Astegiano M, Leonarduzzi G, et al. (2011) Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease. Curr Med Chem 18, 4851-4865.
10. Mazzon E, Esposito E, Di Paola R, et al. (2009) Effects of verbascoside biotechnologically produced by Syringa vulgaris plant cell cultures in a rodent model of colitis. Naunyn Schmiedebergs Arch Pharmacol 380, 79-94.
11. Hausmann M, Obermeier F, Paper DH, et al. (2007) In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis. Clin Exp Immunol 148, 373-381.
12. Nishitani Y, Yamamoto K, Yoshida M, et al. (2013) Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-kB inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors 39, 522-533.
13. Lenoir L, Joubert-Zakeyh J, Texier O, et al. (2012) Aloysia triphylla infusion protects rats against dextran sulfate sodiuminduced colonic damage. J Sci Food Agric 92, 1570-1572.
14. Lenoir L, Rossary A, Joubert-Zakeyh J, et al. (2011) Lemon verbena infusion consumption attenuates oxidative stress in dextran sulfate sodium-induced colitis in the rat. Dig Dis Sci 56, 3534-3545.
15. D'Archivio M, Filesi C, Di Benedetto R, et al. (2007) Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 43, 348-361.
16. Crozier A, Del Rio D & Clifford MN (2010) Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31, 446-467.
17. Dryden GW, Song M & McClain C (2006) Polyphenols and gastrointestinal diseases. Curr Opin Gastroenterol 22, 165-170.
18. Tomas-Barberan FA & Andres-Lacueva C (2012) Polyphenols and health: current state and progress. J Agric Food Chem 60, 8773-8775.
19. Solomon L, Mansor S, Mallon P, et al. (2010) The dextran sulphate sodium (DSS) model of colitis: an overview. Comp Clin Pathol 19, 235-239.
20. Talavéra S, Felgines C, Texier O, et al. (2004) Anthocyanins are efficiently absorbed from the small intestine in rats. J Nutr 134, 2275-2279.
21. Carnat A, Carnat AP, Chavignon O, et al. (1995) Luteolin 7-diglucuronide, the major flavonoid compound from Aloysia triphylla and Verbena officinalis. Planta Med 61, 490.
22. Chen Z, Chen M, Pan H, et al. (2011) Role of catechol-O-methyltransferase in the disposition of luteolin in rats. Drug Metab Dispos 39, 667-674.
23. Funes L, Fernández-Arroyo S, Laporta O, et al. (2009) Correlation between plasma antioxidant capacity and verbascoside levels in rats after oral administration of lemon verbena extract. Food Chem 117, 589-598.
24. Chen T, Li LP, Lu XY, et al. (2007) Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J Agric Food Chem 55, 273-277.
25. Galvano F, La Fauci L, Vitaglione P, et al. (2007) Bioavailability, antioxidant and biological properties of the natural free-radical scavengers cyanidin and related glycosides. Ann Ist Super Sanita 43, 382-393.
26. Chen Z, Kong S, Song F, et al. (2012) Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats. Fitoterapia 83, 1616-1622.
27. de Boer VC, Dihal AA, van der Woude H, et al. (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135, 1718-1725.
28. Felgines C, Texier O, Besson C, et al. (2002) Blackberry anthocyanins are slightly bioavailable in rats. J Nutr 132, 1249-1253.
29. Hanske L, Loh G, Sczesny S, et al. (2009) The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J Nutr 139, 1095-1102.
30. Schoefer L, Mohan R, Schwiertz A, et al. (2003) Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol 69, 5849-5854.
31. Braune A, Gutschow M, Engst W, et al. (2001) Degradation of quercetin and luteolin by Eubacterium ramulus. Appl Environ Microbiol 67, 5558-5567.
32. Falé PLV, Madeira PJA, Florêncio MH, et al. (2011) Function of Plectranthus barbatus herbal tea as neuronal acetylcholinesterase inhibitor. Food Funct 2, 130-136.
33. Fecka I & Turek S (2007) Determination of water-soluble polyphenolic compounds in commercial herbal teas from Lamiaceae: peppermint, melissa, and sage. J Agric Food Chem 55, 10908-10917.
34. Chen Z, Tu M, Sun S, et al. (2012) The exposure of luteolin is much lower than that of apigenin in oral administration of Flos Chrysanthemi extract to rats. Drug Metab Pharmacokinet 27, 162-168.
35. Shimoi K, Okada H, Furugori M, et al. (1998) Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 438, 220-224.
36. Crespy V, Morand C, Besson C, et al. (2003) The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am J Physiol Gastrointest Liver Physiol 284, G980-G988.
37. Wu YT, Lin LC, Sung JS, et al. (2006) Determination of acteoside in Cistanche deserticola and Boschniakia rossica and its pharmacokinetics in freely-moving rats using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 844, 89-95.
38. Gonthier MP, Verny MA, Besson C, et al. (2003) Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 133, 1853-1859.
39. Baba S, Osakabe N, Natsume M, et al. (2004) Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid. Life Sci 75, 165-178.
40. Lafay S, Morand C, Manach C, et al. (2006) Absorption and metabolism of caffeic acid and chlorogenic acid in the small intestine of rats. Br J Nutr 96, 39-46.
41. Wittemer SM, Ploch M, Windeck T, et al. (2005) Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine 12, 28-38.
42. Griffiths LA & Smith GE (1972) Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. Biochem J 128, 901-911.
43. Venkatraman A, Ramakrishna BS, Pulimood AB, et al. (2000) Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate. Scand J Gastroenterol 35, 1053-1059.
44. Perse M & Cerar A (2012) Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol (epublication 14 May 2012).
45. Nanda Kumar NS, Balamurugan R, Jayakanthan K, et al. (2008) Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate. J Gastroenterol Hepatol 23, 1834-1839.
46. Lara-Villoslada F, Debras E, Nieto A, et al. (2006) Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin Nutr 25, 477-488.